Tag Archive | "rare diseases"

Alexion to buy Synageva Biopharma

Tags: ,

Alexion Pharmaceuticals have entered into a definitive agreement pursuant to which Alexion will acquire Synageva for consideration of $115 in cash and 0.6581 Alexion shares, for each share of Synageva, implying a total per share value of $230 based on the nine day volume-weighted average closing price of Alexion stock through May 5, 2015. Read the full story

Biomarin: Relentlessly pursuing early stage science opportunities

Tags: , ,

Biomarin is a fast growing biopharmaceutical company developing treatments for serious unmet medical conditions and rare diseases. Read the full story